The Effect of Melatonin and Its Agonist on Bone Metabolism A Scoping Review
Main Article Content
Abstract
Objectives : To assess the effects of melatonin and its agonist on bone tissue through a scoping review of the literature.
Materials and Methods: The keywords were searched on Scopus, Web of Science, and PubMed. Title and abstracts were reviewed to exclude the duplicates and irrelevant articles. The full-text articles were then screened in accordance with the inclusion criteria.
Results: Of the 5,383 identified articles [PubMed=5,508, Web of Science=122, Scopus=53], only 3 studies qualified to be included in the scoping review based on the inclusion criteria. The first study assessed effects of the oral melatonin on bone integrity and mass in postmenopausal osteopenic women through dual X-ray absorptiometry, quantitative computed tomography (QCT), high-resolution peripheral QCT (HR-pQCT), determined calciotropic hormones and bone markers. The other two studies evaluated radiographic and clinical outcomes such as Perio test, Angulated Bleeding test, Pink Esthetic Score (PES), Gingival index (GI), Peri-implant sulcus depth (PD), Wound healing index (WHI), Linear measurements of bone loss around implant and Densitometric analysis of dental implants with the local application of melatonin. All studies showed an improved outcome parameters in comparison with the control group.
Conclusion: Based on the findings of the included studies, it was found that melatonin improved bone mineral density, increased marginal bone level and minimized root resorption aiding in implant stability. The findings were suggestive that melatonin has osteoinductive properties and inhibitory effect on osteoclastic activity.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
References
Tordjman S, Chokron S, Delorme R, Charrier A, Bellissant E, Jaafari N, et al. Melatonin: Pharmacology, Functions and Therapeutic Benefits. Curr Neuropharmacol. 2017 Apr;15[3]:434–43.
Zawilska JB, Skene DJ, Arendt J. Physiology and pharmacology of melatonin in relation to biological rhythms. Pharmacol Rep. 2009 Jun;61[3]:383–410.
Liu J, Huang F, He HW. Melatonin Effects on Hard Tissues: Bone and Tooth. IJMS. 2013 May 10;14[5]:10063-74.
Guardiola-Lemaître B. Toxicology of melatonin. J Biol Rhythms. 1997 Dec;12[6]:697–706.
Golan K, Kollet O, Markus RP, Lapidot T. Daily light and darkness onset and circadian rhythms metabolically synchronize hematopoietic stem cell differentiation and maintenance: The role of bone marrow norepinephrine, tumor necrosis factor, and melatonin cycles. Exp Hematol. 2019 Oct;78:1–10.
Claustrat B, Leston J. Melatonin: Physiological effects in humans. Neurochirurgie. 2015 Jun;61[2–3]:77–84.
Balaji TM, Vasanthi HR, Rao SR. Gingival, plasma and salivary levels of melatonin in periodontally healthy individuals and chronic periodontitis patients: a pilot study. J Clin Diagn Res. 2015 Mar;9[3]:ZC23-25.
Balaji TM, Varadarajan S, Jagannathan R, Mahendra J, Fageeh HI, Fageeh HN, et al. Melatonin as a Topical/Systemic Formulation for the Management of Periodontitis: A Systematic Review. Materials [Basel]. 2021 May 6;14[9]:2417.
Abdolsamadi H, Goodarzi MT, Ahmadi Motemayel F, Jazaeri M, Feradmal J, Zarabadi M, et al. Reduction of Melatonin Level in Patients with Type II Diabetes and Periodontal Diseases. J Dent Res Dent Clin Dent Prospects. 2014;8[3]:160–5.
Srinath R, Acharya AB, Thakur SL. Salivary and gingival crevicular fluid melatonin in periodontal health and disease. J Periodontol. 2010 Feb;81[2]:277–83.
Jan JE, Freeman RD. Melatonin therapy for circadian rhythm sleep disorders in children with multiple disabilities: what have we learned in the last decade? Dev Med Child Neurol. 2004 Nov;46[11]:776–82.
De Leersnyder H. Inverted rhythm of melatonin secretion in Smith-Magenis syndrome: from symptoms to treatment. Trends Endocrinol Metab. 2006 Sep;17[7]:291–8.
Miyamoto A, Oki J, Takahashi S, Okuno A. Serum melatonin kinetics and long-term melatonin treatment for sleep disorders in Rett syndrome. Brain Dev. 1999 Jan;21[1]:59–62.
Paavonen EJ, Nieminen-von Wendt T, Vanhala R, Aronen ET, von Wendt L. Effectiveness of melatonin in the treatment of sleep disturbances in children with Asperger disorder. J Child Adolesc Psychopharmacol. 2003;13[1]:83–95.
Cutando A, Aneiros-Fernández J, López-Valverde A, Arias-Santiago S, Aneiros-Cachaza J, Reiter RJ. A new perspective in Oral health: potential importance and actions of melatonin receptors MT1, MT2, MT3, and RZR/ROR in the oral cavity. Arch Oral Biol. 2011 Oct;56[10]:944–50.
Cutando A, Gómez-Moreno G, Arana C, Acuña-Castroviejo D, Reiter RJ. Melatonin: potential functions in the oral cavity. J Periodontol. 2007 Jun;78[6]:1094–102.
Uslu S, Uysal A, Oktem G, Yurtseven M, Tanyalçin T, Başdemir G. Constructive effect of exogenous melatonin against osteoporosis after ovariectomy in rats. Anal Quant Cytol Histol. 2007 Oct;29[5]:317–25.
El-Gammal MY, Salem AS, Anees MM, Tawfik MA. Clinical and Radiographic Evaluation of Immediate Loaded Dental Implants With Local Application of Melatonin: A Preliminary Randomized Controlled Clinical Trial. J Oral Implantol. 2016 Apr;42[2]:119–25.
Hazzaa HHA, El-Kilani NS, Elsayed SAE, Abd El Massieh PM. Evaluation of Immediate Implants Augmented with Autogenous Bone/Melatonin Composite Graft in the Esthetic Zone: A Randomized Controlled Trial. J Prosthodont. 2019 Feb; 28[2]:e637–42.
Amstrup AK, Sikjaer T, Heickendorff L, Mosekilde L, Rejnmark L. Melatonin improves bone mineral density at the femoral neck in postmenopausal women with osteopenia: a randomized controlled trial. J Pineal Res. 2015 Sep;59[2]:221–9.
Sandyk R, Anastasiadis PG, Anninos PA, Tsagas N. Is postmenopausal osteoporosis related to pineal gland functions? Int J Neurosci. 1992 Feb;62[3–4]:215–25.
Harms HM, Kaptaina U, Külpmann WR, Brabant G, Hesch RD. Pulse amplitude and frequency modulation of parathyroid hormone in plasma. J Clin Endocrinol Metab. 1989 Oct;69[4]:843–51.
Markowitz ME, Arnaud S, Rosen JF, Thorpy M, Laximinarayan S. Temporal interrelationships between the circadian rhythms of serum parathyroid hormone and calcium concentrations. J Clin Endocrinol Metab. 1988 Nov;67[5]:1068–73.
Gómez-Moreno G, Aguilar-Salvatierra A, Boquete-Castro A, Guardia J, Piattelli A, Perrotti V, et al. Outcomes of topical applications of melatonin in implant dentistry: a systematic review. Implant Dent. 2015 Feb;24[1]:25–30.
Permuy M, López-Peña M, González-Cantalapiedra A, Muñoz F. Melatonin: A Review of Its Potential Functions and Effects on Dental Diseases. Int J Mol Sci. 2017 Apr 19;18[4]:E865.
Cutando A, Gómez-Moreno G, Arana C, Muñoz F, Lopez-Peña M, Stephenson J, et al. Melatonin stimulates osteointegration of dental implants. J Pineal Res. 2008 Sep;45[2]:174–9.
Son JH, Cho YC, Sung IY, Kim IR, Park BS, Kim YD. Melatonin promotes osteoblast differentiation and mineralization of MC3T3-E1 cells under hypoxic conditions through activation of PKD/p38 pathways. J Pineal Res. 2014 Nov;57[4]:385–92.